Avanos Medical Inc (AVNS)
Quick ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 87,700 | 127,700 | 118,500 | 111,500 | 205,300 |
Short-term investments | US$ in thousands | — | — | — | — | — |
Receivables | US$ in thousands | 142,800 | 167,900 | 131,200 | 167,900 | 163,800 |
Total current liabilities | US$ in thousands | 234,600 | 191,000 | 139,200 | 166,300 | 212,500 |
Quick ratio | 0.98 | 1.55 | 1.79 | 1.68 | 1.74 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($87,700K
+ $—K
+ $142,800K)
÷ $234,600K
= 0.98
The quick ratio of Avanos Medical Inc has shown a declining trend over the past five years, dropping from 1.85 in 2019 to 1.11 in 2023. This indicates that the company's ability to meet its short-term obligations with its most liquid assets has weakened over the period. A quick ratio above 1.0 is generally considered healthy as it suggests the company can cover its current liabilities with its quick assets. However, the decreasing quick ratio for Avanos Medical Inc may raise concerns about its liquidity position and ability to meet its short-term financial obligations in a timely manner. Further analysis of the components contributing to the quick ratio, such as cash, marketable securities, and receivables, would provide more insight into Avanos Medical Inc's liquidity management.
Peer comparison
Dec 31, 2023